DNA methylation profiling in MEN1-related pancreatic neuroendocrine tumors reveals a potential epigenetic target for treatment

E. B. Conemans, L. Lodewijk, C. B. Moelans, G. J. A. Offerhaus, C. R. C. Pieterman, F. H. Morsink, O. M. Dekkers, W. W. de Herder, A. R. Hermus, A. N. van der Horst-Schrivers, M. L. Drent, P. H. Bisschop, B. Havekes, L. A. A. Brosens, K. M. A. Dreijerink, I. H. M. Borel Rinkes, H. Th M. Timmers, G. D. Valk, M. R. Vriens

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)153-160
Number of pages8
JournalEuropean Journal of Endocrinology
Volume179
Issue number3
DOIs
Publication statusPublished - 1 Sep 2018

Keywords

  • PROMOTER HYPERMETHYLATION
  • CANCER
  • MENIN
  • EXPRESSION
  • GENES
  • HEREDITARY
  • PATHOLOGY
  • MUTATION
  • PATHWAY
  • MGMT

Cite this

Conemans, E. B., Lodewijk, L., Moelans, C. B., Offerhaus, G. J. A., Pieterman, C. R. C., Morsink, F. H., Dekkers, O. M., de Herder, W. W., Hermus, A. R., van der Horst-Schrivers, A. N., Drent, M. L., Bisschop, P. H., Havekes, B., Brosens, L. A. A., Dreijerink, K. M. A., Rinkes, I. H. M. B., Timmers, H. T. M., Valk, G. D., & Vriens, M. R. (2018). DNA methylation profiling in MEN1-related pancreatic neuroendocrine tumors reveals a potential epigenetic target for treatment. European Journal of Endocrinology, 179(3), 153-160. https://doi.org/10.1530/EJE-18-0195